From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins

被引:25
|
作者
Desrat, S. [1 ]
Remeur, C. [1 ]
Geny, C. [1 ]
Riviere, G. [1 ]
Colas, C. [1 ]
Dumontet, V. [1 ]
Birlirakis, N. [1 ]
Iorga, B. I. [1 ]
Roussi, F. [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, CNRS UPR 2301, F-91198 Gif Sur Yvette, France
关键词
DERIVATIVES; FAMILY; EXPLORATION; DISCOVERY;
D O I
10.1039/c4cc01830c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The synthesis of one of the most potent dual inhibitors of the antiapoptotic proteins Bcl-xL and Mcl-1 is reported. This analogue of a natural sesquiterpenoid dimer meiogynin A was elaborated by a convergent asymmetric synthesis with 36% yield in ten steps.
引用
收藏
页码:8593 / 8596
页数:4
相关论文
共 50 条
  • [41] BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
    Lee, Erinna F.
    Harris, Tiffany J.
    Tran, Sharon
    Evangelista, Marco
    Arulananda, Surein
    John, Thomas
    Ramnac, Celeste
    Hobbs, Chloe
    Zhu, Haoran
    Gunasingh, Gency
    Segal, David
    Behren, Andreas
    Cebon, Jonathan
    Dobrovic, Alexander
    Mariadason, John M.
    Strasser, Andreas
    Rohrbeck, Leona
    Haass, Nikolas K.
    Herold, Marco J.
    Fairlie, W. Douglas
    CELL DEATH & DISEASE, 2019, 10
  • [42] BCL-XS CAN ANTAGONIZE THE ANTI-APOPTOTIC PROPERTIES OF BCL-XL
    MINN, AJ
    BOISE, LH
    THOMPSON, CB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 78 - 78
  • [43] Synthesis of a rhodanine-based compound library targeting Bcl-XL and Mcl-1
    Bernardo, Paul H.
    Sivaraman, Thirunavukkarasu
    Wan, Kah-Fei
    Xu, Jin
    Krishnamoorthy, Janarthanan
    Song, Chun Meng
    Tian, Liming
    Chin, Jasmine S. F.
    Lim, Diane S. W.
    Mok, Henry Y. K.
    Yu, Victor C.
    Tong, Joo Chuan
    Chai, Christina L. L.
    PURE AND APPLIED CHEMISTRY, 2011, 83 (03) : 723 - 731
  • [44] Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer
    Yumin Wei
    Liping Zhang
    Chao Wang
    Zefeng Li
    Mingjie Luo
    Guomin Xie
    Xingjiu Yang
    Mengyuan Li
    Shuyue Ren
    Dongbing Zhao
    Ran Gao
    Jia-Nan Gong
    Animal Models and Experimental Medicine, 2023, 6 (03) : 245 - 254
  • [45] Modulation of Membrane Interactions of Anti-Apoptotic Regulator Bcl-xL by Lipids
    Vargas-Uribe, Mauricio
    Rodnin, Mykola V.
    Ladokhin, Alexey S.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 608A - 608A
  • [46] Bcl-xL promotes metastasis independent of its anti-apoptotic activity
    Soyoung Choi
    Zhengming Chen
    Laura H. Tang
    Yuanzhang Fang
    Sandra J. Shin
    Nicole C. Panarelli
    Yao-Tseng Chen
    Yi Li
    Xuejun Jiang
    Yi-Chieh Nancy Du
    Nature Communications, 7
  • [47] Inhibition of anti-apoptotic Bcl-xL mitigates the radioresistance of mesothelioma cells
    Jackson, M.
    Ashton, M.
    Chalmers, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1279 - S1279
  • [48] IMMUNOHISTOCHEMISTRY FOR ANTI-APOPTOTIC PROTEINS MCL-1 AND BCL-X IN CANINE NORMAL TISSUES AND LYMPHOMA SAMPLES
    Zeller, S.
    Keller, S.
    Schade, B.
    Keller, B.
    Brugnera, E.
    Guscetti, F.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 275 - 275
  • [49] Innate Conformational Dynamics Drive Binding Specificity in Anti-Apoptotic Proteins Mcl-1 and Bcl-2
    Wolf, Esther
    Lento, Cristina
    Pu, Jinyue
    Dickinson, Bryan C.
    Wilson, Derek J.
    BIOCHEMISTRY, 2023, 62 (11) : 1619 - 1630
  • [50] Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
    Murray, James B.
    Davidson, James
    Chen, Ijen
    Davis, Ben
    Dokurno, Pawel
    Graham, Christopher J.
    Harris, Richard
    Jordan, Allan
    Matassova, Natalia
    Pedder, Christopher
    Ray, Stuart
    Roughley, Stephen D.
    Smith, Julia
    Walmsley, Claire
    Wang, Yikang
    Whitehead, Neil
    Williamson, Douglas S.
    Casara, Patrick
    Le Diguarher, Thierry
    Hickman, John
    Stark, Jerome
    Kotschy, Andra
    Geneste, Olivier
    Hubbard, Roderick E.
    ACS OMEGA, 2019, 4 (05): : 8892 - 8906